NATURE’S SUNSHINE PRODUCTS, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, shares, acquired for the quarter ending 2026-06-30 was 93.00K shares, a 90.44% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, shares, acquired for the quarter ending 2026-03-31 was 20.00K shares, a 47.37% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, shares, acquired for the quarter ending 2025-12-31 was 131.00K shares.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, shares, acquired for the quarter ending 2025-09-30 was 118.00K shares, a 110.71% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. treasury stock, shares, acquired for fiscal 2025 was 1.26M shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2026-06-30 | 93.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 362.00K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 20.00K shares 10-Q · filed 2026-05-07 | 1.24M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 131.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 1.26M shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 118.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | |
| 2025-06-30 | 973.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | |
| 2025-03-31 | 38.00K shares 10-Q · filed 2026-05-07 | |
| 2024-09-30 | 56.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |